ENHANCED LYTIC EFFICACY OF MULTIPLE BOLUS INJECTIONS OF TISSUE PLASMINOGEN-ACTIVATOR IN DOGS

被引:7
|
作者
KLABUNDE, RE [1 ]
BURKE, SE [1 ]
HENKIN, J [1 ]
机构
[1] ABBOTT LABS,DEPT THROMBOLYT VENTURE D48R,ABBOTT PK,IL 60064
关键词
Alpha-2-Antiplasmin; Clot Lysis; Fibrinogen; Fibrinolysis; Thrombolysis; Tissue Plasminogen Activator;
D O I
10.1016/0049-3848(91)90256-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to compare the lytic efficacy of tissue plasminogen activator (tPA) following different dosing regimens. Radiolabelled clots from dog whole blood were inserted into an extracorporeal jugular loop in anesthetized dogs. Clot size (counts/min) was continuously recorded, tPA was administered as a single 1 min bolus of 0.4 mg/kg, as four multiple bolus injections of 0.1 mg/kg each at 30 min intervals, or as an initial bolus (0.04 mg/kg) followed by a 30 min infusion of 0.36 mg/kg (10%/90%, bolus/infusion). Multiple injections of the same total dose of tPA resulted in 76% and 51% greater clot lysis than single bolus injection or bolus/infusion regimen, respectively, measured 120 min after initial dosing. There were no differences in fibrinogen, plasminogen or alpha-2-antiplasmin between the different treatment groups at 120 min. © 1990.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 50 条
  • [41] KINETIC-ANALYSIS OF LIPOPROTEIN(A) INHIBITION OF PLASMINOGEN ACTIVATION BY TISSUE PLASMINOGEN-ACTIVATOR INVITRO
    LEERINK, CB
    GIMPEL, JA
    KORTLANDT, W
    BOUMA, BN
    VANRIJN, HJM
    FIBRINOLYSIS, 1991, 5 (04) : 233 - 238
  • [42] INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE PLASMINOGEN-ACTIVATOR LEVELS IN SUBJECTS WITH ELECTROCARDIOGRAPHIC ABNORMALITY INDICATIVE OF ISCHEMIC-HEART-DISEASE - A CROSS-SECTIONAL STUDY IN NORSJO, SWEDEN
    HELLSTEN, G
    BOMAN, K
    BJERLE, P
    BLOM, P
    NILSSON, TK
    EUROPEAN HEART JOURNAL, 1992, 13 (01) : 57 - 60
  • [43] EUGLOBULIN CLOT LYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS REDUCED IN SUBJECTS WITH INCREASED LEVELS OF LIPOPROTEIN(A)
    AZNAR, J
    ESTELLES, A
    BRETO, M
    ESPANA, F
    ALOS, T
    THROMBOSIS RESEARCH, 1992, 66 (05) : 569 - 582
  • [44] Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke
    Zamanlu, Masumeh
    Farhoudi, Mehdi
    Eskandani, Morteza
    Mahmoudi, Javad
    Barar, Jaleh
    Rafi, Mohammad
    Omidi, Yadollah
    JOURNAL OF DRUG TARGETING, 2018, 26 (02) : 95 - 109
  • [45] BIOLOGICAL SIGNIFICANCE OF TISSUE PLASMINOGEN-ACTIVATOR CONTENT IN BRAIN-TUMORS
    SAWAYA, R
    RAMO, OJ
    SHI, ML
    MANDYBUR, G
    JOURNAL OF NEUROSURGERY, 1991, 74 (03) : 480 - 486
  • [46] INTRACISTERNAL RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE
    FINDLAY, JM
    WEIR, BKA
    KASSELL, NF
    DISNEY, LB
    GRACE, MGA
    JOURNAL OF NEUROSURGERY, 1991, 75 (02) : 181 - 188
  • [47] LOCALIZATION OF TISSUE PLASMINOGEN-ACTIVATOR ON EXPERIMENTAL MICROTHROMBI IN RATS - MICROAUTORADIOGRAPHIC OBSERVATIONS
    KIMATA, H
    KOIDE, T
    NAKAJIMA, K
    KONDO, S
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (01): : 25 - 33
  • [48] VENOUS THROMBOSIS AND TISSUE PLASMINOGEN-ACTIVATOR RELEASE DEFICIENCY - A FAMILY STUDY
    PATRASSI, GM
    SARTORI, MT
    VIERO, ML
    BOSCARO, M
    BOERI, G
    GIROLAMI, A
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (02) : 231 - 235
  • [49] EFFECT OF ULTRASOUND ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR INDUCED THROMBOLYSIS
    LAUER, CG
    BURGE, R
    TANG, DB
    BASS, BG
    GOMEZ, ER
    ALVING, BM
    CIRCULATION, 1992, 86 (04) : 1257 - 1264
  • [50] DETERMINANTS OF CLEARANCE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND THEIR PHARMACOLOGICAL IMPLICATIONS
    ORD, JM
    OWENSBY, DA
    BILLADELLO, JJ
    SOBEL, BE
    FIBRINOLYSIS, 1990, 4 (04) : 203 - 209